Back to Dashboard
TEVA · Healthcare

Teva Pharmaceutical Industries

USA Healthcare Filing: 2023-12-31
32/100
Smart-money confidence1 of 3 sources positive
Below average interest

company insiders are selling

What this band has actually done: stocks scoring 25–45 beat the S&P 500 over the next three months 45.3% of the time, across 39,662 cases since 2015. That is below a coin flip — and so is every other band, because the median stock loses to a cap-weighted index. How we measured this

Hedge funds
58
Congress
No data
Insiders
0
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Market cap
$46.4B
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Exchange
NYSE
About TEVA PHARMACEUTICAL INDUSTRIES

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system…

Who's behind the signal
Every informed buyer we can see on TEVA, across all three feeds.
Hedge funds · 11
Citadel Advisors New position
D.E. Shaw & Co Increased +29%
AQR Capital Management Increased +43%
+5 more in the full breakdown below ↓
Insiders
Company insiders Selling
Recent sells11
Congressional trades · 5 on record
Disclosures from 2016-10-19 to 2026-03-30
Trade date Member Chamber Action Amount
2026-03-30 Alan Armstrong · R-OK Senate Bought $1,001 - $15,000
2020-11-13 Greg Gianforte · R-MT House Bought $15,001 - $50,000
2020-05-07 Donna E. Shalala · D-FL House Sold $1,001 - $15,000
2017-06-15 Patty Murray · D-WA Senate Sold $1,001 - $15,000
2016-10-19 Angus S. King, Jr. · I-ME Senate Sold $1,001 - $15,000
Not a model pick — but on our radar. TEVA PHARMACEUTICAL INDUSTRIES isn't in the top-10 model right now, but 11 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
11
Investors
2
New positions
4
Increasing
4
Decreasing
1
Unchanged
Price History
Loading price data...
A member of Congress bought A member sold
Return: High: Low:

Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.

Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Portfolio Allocation
How much of each investor's portfolio is allocated to TEVA PHARMACEUTICAL INDUSTRIES
Insider Trading (Form 4)
Recent trades by company officers and directors — filed within 2 days of each trade
Bearish
Sentiment
0
Buys
11
Sells
Date Insider Title Action Shares Price Value
2026-09-18 Savage Brian Insider SELL 314 $38.70 $12,153
2026-09-18 Savage Brian Insider SELL 2,525 $39.15 $98,841
2026-09-18 Savage Brian Insider SELL 4,503 $38.69 $174,221
2026-09-18 MIGNONE ROBERTO Insider SELL 367,600 $39.06 $14,356,802
2026-08-21 Weiss Amir Insider SELL 2,500 $37.63 $94,077
2026-08-21 Weiss Amir Insider SELL 6,945 $37.61 $261,224
2026-08-21 Satchi-Fainaro Ronit Insider SELL 415 $37.25 $15,459
2026-08-17 Lippman Evan Insider SELL 18,600 $36.57 $680,291
2026-08-05 Zaks Tal Zvi Insider SELL 17 $34.87 $593
2026-08-03 Jover Placid Insider SELL 12,827 $34.88 $447,351
2026-08-03 Hughes Eric A Insider SELL 25,578 $34.88 $892,051
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell TEVA PHARMACEUTICAL INDUSTRIES or any security.

Get the Weekly Update

Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime